Emily Roberts

Davis Polk advised Equinix, Inc. on an SEC-registered offering of $2.6 billion aggregate principal amount of senior notes. The offering consisted of $500 million aggregate principal amount…

Davis Polk advised the initial purchasers on a Rule 144A offering by Jazz Investments I Limited, a wholly owned subsidiary of Jazz Pharmaceuticals plc, of $850 million aggregate…

Davis Polk advised the joint book-running managers in connection with a $325 million SEC-registered common stock offering by Turning Point Therapeutics, Inc. The common stock is listed…

Davis Polk advised the representative of the initial purchasers in connection with a Rule 144A/Regulation S offering by Uber Technologies, Inc. of $900 million aggregate principal amount of…

Davis Polk advised Equinix, Inc. on its SEC-registered follow-on public offering of 2,587,500 shares of common stock including 337,500 shares that the underwriters purchased pursuant to…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 1.750% notes due 2030. Texas Instruments designs and…

Davis Polk advised the joint book-running managers in connection with a $138 million SEC-registered common stock and pre-funded warrants offering by Aeglea, including the full exercise…

Davis Polk advised the representatives of the several underwriters in connection with a $587 million SEC-registered offering of 17,250,000 shares of common stock of Grocery Outlet…

Davis Polk advised Texas Instruments Incorporated on its SEC-registered debt offering of $750 million aggregate principal amount of 1.375% notes due 2025.  Texas Instruments designs…

Davis Polk advised the initial purchasers in connection with a Rule 144A offering by Revance Therapeutics, Inc. of $287.5 million aggregate principal amount of its 1.75% convertible senior…